Zevra Therapeutics (ZVRA) EBT (2014 - 2026)
Zevra Therapeutics (ZVRA) posted EBT of $44.8 million for Q1 2026, up 253.73% on a QoQ basis from $12.7 million in Q4 2025, and up 2437.19% year-over-year from $1.8 million in Q1 2025.
Zevra Therapeutics (ZVRA) EBT (2014 - 2026) Analysis & Trends
Zevra Therapeutics' EBT history runs 13 years deep, the most recent figure standing at $44.8 million for Q1 2026.
- Quarterly EBT rose 2437.19% year-over-year to $44.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $133.4 million (up 277.0% YoY) and the FY2025 annual result came in at $86.7 million, up 196.16% from the prior year.
- EBT was $44.8 million for Q1 2026 at Zevra Therapeutics, up from $12.7 million in the prior quarter.
- Across five years, EBT topped out at $76.9 million in Q2 2025 and bottomed at -$33.2 million in Q3 2024.
- A 5-year average of -$1.5 million and a median of -$5.7 million in 2022 frame the typical range for EBT.
- Annual changes were most pronounced in 2024 — EBT slumped 650.09% — and 2026, when it soared 2437.19%.
- Zevra Therapeutics' EBT stood at -$3.0 million in 2022, then slumped by 561.74% to -$19.9 million in 2023, then decreased by 2.39% to -$20.4 million in 2024, then surged by 162.19% to $12.7 million in 2025, then surged by 253.73% to $44.8 million in 2026.
- Business Quant data shows ZVRA's EBT at $44.8 million in Q1 2026, $12.7 million in Q4 2025, and -$977000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn | 44.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.80 Mn |
| Dec 31, 2025 | 12.67 Mn |
| Sep 30, 2025 | -977,000.00 |
| Jun 30, 2025 | 76.91 Mn |
| Mar 31, 2025 | -1.92 Mn |
| Dec 31, 2024 | -20.37 Mn |
| Sep 30, 2024 | -33.23 Mn |
| Jun 30, 2024 | -19.86 Mn |
| Mar 31, 2024 | -16.69 Mn |
| Dec 31, 2023 | -19.89 Mn |
| Sep 30, 2023 | -10.19 Mn |
| Jun 30, 2023 | -2.65 Mn |
| Mar 31, 2023 | -13.32 Mn |
| Dec 31, 2022 | -3.01 Mn |
| Sep 30, 2022 | -5.70 Mn |
| Jun 30, 2022 | -21.93 Mn |
| Mar 31, 2022 | 10.48 Mn |
| Dec 31, 2021 | -2.67 Mn |
| Sep 30, 2021 | -1.76 Mn |
| Jun 30, 2021 | 6.20 Mn |